0.33
-0.0007(-0.21%)
Currency In USD
| Previous Close | 0.33 |
| Open | 0.33 |
| Day High | 0.33 |
| Day Low | 0.32 |
| 52-Week High | 39.84 |
| 52-Week Low | 0.25 |
| Volume | 394,810 |
| Average Volume | 1.49M |
| Market Cap | 7.85M |
| PE | 0.11 |
| EPS | 2.88 |
| Moving Average 50 Days | 2.14 |
| Moving Average 200 Days | 6.48 |
| Change | -0 |
If you invested $1000 in Cyclacel Pharmaceuticals, Inc. (CYCC) 10 years ago, it would be worth $0.01 as of July 01, 2025 at a share price of $0.33. Whereas If you bought $1000 worth of Cyclacel Pharmaceuticals, Inc. (CYCC) shares 5 years ago, it would be worth $0.3 as of July 01, 2025 at a share price of $0.33.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock
GlobeNewswire Inc.
Jun 20, 2025 8:30 PM GMT
KUALA LUMPUR, June 20, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a securities p
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
GlobeNewswire Inc.
Jun 03, 2025 8:15 PM GMT
KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has r
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
GlobeNewswire Inc.
May 07, 2025 1:00 PM GMT
BERKELEY HEIGHTS, NJ, May 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implem